Back

Kymera Therapeutics Stock Predictions

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Sell

KYMR
Kymera Therapeutics

Last Price:

$40.69

Seasonality Move:

2.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Kymera Therapeutics Stock Forecast

Over the next 52 weeks, Kymera Therapeutics has on average historically fallen by 1.3% based on the past 4 years of stock performance.
Kymera Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Is Kymera Therapeutics Stock Undervalued?

The current Kymera Therapeutics [KYMR] share price is $40.79. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Kymera Therapeutics has on average historically fallen by 1.3% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Sell

Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics overpriced?

Kymera Therapeutics has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

kymeratx.com

52-Week Data

52-Week High:

53.27

52-Week Low:

22.35

Prediction Charts

Market Cap:

2.6B

Price in USD:

40.79

Volume:

219.2K

Beta:

2.14

Technical Analysis

SMA50:

45.84

SMA100:

45.80

SMA200:

41.30

52-Wk Change:

58.72%

Stock Predictions

Is Kymera Therapeutics stock public?

Yes, Kymera Therapeutics is a publicly traded company.
What is the Kymera Therapeutics stock quote today?

The Kymera Therapeutics stock price is 40.79 USD today.
How to buy Kymera Therapeutics stock online?

You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-4	46.60	46.02	47.36	45.22
Dec-5	45.71	44.08	46.37	43.66
Dec-6	44.02	46.67	47.42	44.02
Dec-9	46.70	43.65	47.41	43.23
Dec-10	43.81	45.05	45.38	43.06
Dec-11	45.75	45.02	46.66	44.93
Dec-12	44.90	42.17	45.05	41.03
Dec-13	41.81	42.13	43.02	40.95
Dec-16	42.17	43.06	44.17	41.85
Dec-17	42.49	42.30	43.45	41.66
Dec-18	42.95	39.00	42.95	38.62
Dec-19	39.10	39.14	39.59	37.09
Dec-20	38.66	40.64	40.78	38.24
Dec-23	40.34	40.79	40.85	39.69

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.